Conditions

DOXEPIN HYDROCHLORIDE

Drug approval information sourced from the FDA and the PBS. Updated nightly from public government registries. Not medical advice.

Access in Australia

  • This medicine does not currently appear on the PBS Schedule, according to the Pharmaceutical Benefits Scheme. This can mean a higher out of pocket cost. Your doctor can explain the available access pathways.
  • TGA registration data for this medicine is not yet available on Voxsanity.
Updated regularly from public government registries

How it works: Norepinephrine Uptake Inhibitors

Drug class: Other antipruritics

Approval status

FDA Approved

3 April 2023
US Food and Drug Administration

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Regulatory approval does not guarantee this drug is available to you. Availability in Australia depends on PBS listing status, your specific diagnosis, your doctor's assessment, and other clinical factors.

Accessing this drug in Australia

This medicine does not currently appear on the PBS Schedule. Your doctor can explain the available access pathways, which may include the TGA Special Access Scheme ↗.

This information is drawn from publicly available PBS records. It is not medical advice. Consult your doctor about access options for your specific situation.

Reported adverse events (FDA database)

These are the reactions most often reported to the FDA's adverse event reporting system in cases where this medicine was recorded as the suspected cause. Reports that list it only as another medicine the person was taking at the time are excluded, because the reaction in those cases was attributed to a different medicine.

  • COMPLETED SUICIDE — in 23 of 105 such reports
  • TOXICITY TO VARIOUS AGENTS — in 18 of 105 such reports
  • CARDIO-RESPIRATORY ARREST — in 10 of 105 such reports
  • DRUG ABUSE — in 10 of 105 such reports
  • PRODUCT USE IN UNAPPROVED INDICATION — in 9 of 105 such reports

Source: FDA Adverse Event Reporting System (FAERS), openFDA. Counted from a sample of reports in which this medicine was the suspected cause, drawn from 12344 reports that mention it in any role. Reporting is voluntary and unverified, so these counts show what gets reported, not how often a reaction occurs, and they cannot be compared between medicines. Discuss any concerns with your doctor.

Approval data sourced from openFDA (CC0 licence), and the PBS schedule. Updated nightly. This page does not constitute medical advice. Drug availability and PBS listing status may change. Verify current availability and PBS coverage with your doctor or pharmacist.